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1. Introduction 2. Materials and methods 
Adenosine has profound effects on adipose tissue 
metabolism. It is an inhibitor of 13-adrenergic stimula- 
tion of cyclic AMP accumulation [1,2] and lipolysis 
[2-101 in tire isolated rat fat cell. It also opposes the 
effects of adrenaline on phosphate uptake [ 11 ]. In 
vivo, tile nucleoside has been reported to lower plasma 
free fatty acid and glycerol concentrations [8]. The 
effects of adenosine are thought to be mediated by 
two membrane receptors, one requiring an intact 
ribose (R-site) and tile other one an intact purine moi- 
ety [ 12-14] (P-site). Adenosine is rapidly metabolized 
but its effects on the R-site [12-14] are shared by 
purine-substituted analogs uch as N6-(phenylisopro - 
pyl)adenosine that are not deaminated by the enzyme 
adenosine deaminase (EC 3.5.4.4) [15]. 
Lipoprotein lipase (EC 3.1.1.3.4) is the enzyme 
responsible for the hydrolysis and uptake of triglycer- 
ides from circulating chylomicrons and very low density 
lipoproteins [16-19]. The enzyme is thought to be 
located on the endothelial surface of the capillary bed 
of extrahepatic tissues and it can be released into the 
circulation by intravenous injection of heparin 
[ 16-20]. Another heparin-releasable ectoenzyme is
probably located on the outer surface of the endothe- 
lial cells of the liver and it is therefore called hepatic 
lipase [20]. This enzyme has been suggested to hydro- 
lyze high density lipoprotein phospholipids and tri- 
glycerides [21 ]. 
This work was undertaken to find out ifN6-(phenyl - 
isopropyl)adenosine has effects on lipoprotein lipase 
activity and, consequently, on the uptake of circulating 
triglycerides into tissues. 
Male Lewis albino rats (150-250 g body wt) were 
used. They were fed ad libitum with a standard chow 
until injected intraperitoneally with 50-300/al isotonic 
NaC1 with/without N6-(phenylisopropyl)adenosine, at 
which time food was withheld. At the times indicated, 
the animals were anaesthetized with ether and blood 
was drawn by cardiac puncture into heparinized 
syringes. For post-heparin plasma lipase assays, blood 
was drawn 2 min after intravenous injection ofheparin 
(2000 units/kg body wt). The blood was centrifuged 
and the resulting plasma was stored at -20°C until 
assayed. 
Free glycerol was estimated enzymatically by using 
the commercial kit no. 125 032 of Boehringer- 
Mannheim GmbH. Tile assays for porst-heparin plasma 
lipases and the antibody to rat hepatic lipase have been 
described in [22]. The method used to measure hep- 
arin-releasable lipoprotein lipase activity of adipose 
tissue will be presented in detail in the text. 
N6-(phenylisopropyl)Adenosine wasa gift from 
Dr Harald Stork of Boehringer-Mannheim GmbH. 
Glyceroltri-[14C] oleate (49 mCi/mmol) was from the 
Radiochemical Centre (Amersham). Heparin was from 
Medica (ttelsinki). All other reagents were from Sigma 
(St Louis MO). 
3. Results 
First, the finding that N6-(phenylisopropyl)adeno - 
sine lowers the plasma concentration of free glycerol 
[8] was confirmed (table 1). The decrease was dose- 
dependent and a significant effect was observed at 
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Table 1 
Effect of N6-(phenylisopropyl)adenosine on plasma free 
glycerol concentrations in the rat 
Dose n Plasma glycerol 
(#g/kg) (I~M +- SEM) 
0.0 6 462 ± 23 
1.2 3 343 _+ 10 
3.6 5 388 _+ 17 
12.0 3 267 _+ 7 
480.0 3 287 + 3 
Fed rats were injected intraperitoneally with different doses 
of N6-(phenylisopropyl)adenosine and food was withheld. 
The animals were killed 90 min later and plasma glycerol 
was determined as described in the text. n = number of ani- 
mals 
1.2/ag/kg body wt. As noted in [8], the effect was 
transient with a maximum 1-2  h after injection. For 
subsequent studies, 12/ag/kg body wt was chosen. 
To investigate the effect of  N6-(phenylisopropyl)- 
adenosine on post-heparin plasma lipolytic activities, 
rats were anaesthetized and injected intravenously 
with 2000 U heparin/kg body wt 2 h after intraperi- 
toneal injection of  the nucleoside analog (12 ~g/kg 
body wt) or saline and the animals were exsanguinated 
2 min later. It is evident from fig.1 that post-heparin 
plasma l ipoprotein lipase activity was increased by 
the nucleoside analog. The increase was 57% over 
control and it was statistically significant a tp< 0.001 
Student's t-test). In contrast, hepatic lipase activity 
was not affected by N6-(phenylisopropyl)adenosine. 
This finding was confirmed in two similar experiments, 
one of  which was performed using rats that had fasted 
overnight. 
Table 2 
Effect of N<(phenylisopropyl)adenosine on adipose tissue 
lipoprotein lipase activity 
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Fig.1. Stimulation of post-heparin plasma lipoprotein lipase 
activity by N6-(phenylisopropyl)adenosine. Groups of 8 fed 
male rats (av. 168 g body wt) were injected intraperitoneally 
with N~-(phenylisopropyl)adenosine (12 pg/kg) or isotonic 
NaC1 under ether anaesthesia, nd food was withheld. After 
2 h the animals were anaesthetized again and injected intra- 
venously with heparin (2000 U/kg); 2 rain later the animals 
were exsanguinated and plasma lipolytic activities were deter- 
mined as described in the text. Vertical bars indicate SEM; 
white columns, control; shaded columns, N6-(phenylisopropyl)- 
adenosine; HL, hepatic lipase; LPL, lipoprotein lipase. 
n Lipase activity 
(-+ SEM) 
Saline 5 170 ± 36 
N~-(phenylisopropyl) - 
adenosine 5 480 + 94 a 
a Different from control at p < 0.05 
Rats were injected intraperitoneally with N~-(phenylisopropyl)- 
adenosine (12 ug/kg) or isotonic saline and were killed 90 rain 
later. Heparin-releasable lipoprotein lipase activity was deter- 
mined as described in the text. The activities are expressed 
as nmol unesterified fatty acids released, g tissue -1 . h -1. 
n = number of animals 
In subsequent experiments, we investigated the 
effect of  the nucleoside analog on adipose tissue hep- 
arin-releasable ipase activity. N6-(phenylisopropyl). 
Adenosine (12/,tg/kg) or saline were injected intra- 
peritoneally to fed male rats. The animals were killed 
90 min later, and small pieces (~<500 mg) of  perigo- 
nadal adipose tissue were shredded and incubated for 
40 min in 1000~1 25 mM Tr is -125 mM NaC1 5 mM 
KCI -1  mM CAC12-2.5 mM MgC12 1 mM KH2PO4-4 mM 
glucose-2% bovine serum albumin at pH 8.4, in the 
presence of  heparin (50 U/ml) at constant shaking at 
120 Hz at +37°C; 100 ml medium was then assayed 
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for lipoprotein lipase activity as in [23]. The results 
summarized in table 2 show that the activity was 
elevated >2.8-fold after intraperitoneal injection of 
N6-(phenylisopropyl)adenosine. 
4. Discussion 
Adenosine mimicks the action of insulin on cate- 
cholamine-stimulated lipolysis and cyclic AMP accumu- 
lation [ 1 10] and on glucose metabolism [24]. It also 
opposes the effect of adrenaline on phosphate uptake 
[ 11 ]. These results how that adenosine analogs also 
elevate adipose tissue lipoprotein lipase activity and 
therefore may enhance the uptake of circulating tri- 
glycerides into the fat cells. These effects are elicited 
by a purine-substituted analog and therefore they are 
probably mediated by the postulated R-site [12]. The 
R-site adenosine effect may thus prove to be useful in 
the treatment of some forms of diabetes. 
The heparin-releasable lipoprotein lipase activity 
of isolated fat cells and adipose tissue segments 
increases during incubation [16,25-29]. These results 
offer an explanation to this phenomenon. Isolated rat 
fat cells are known to release adenosine into their 
incubation medium [1 ] at pharmacologically effective 
concentrations. As NC(phenylisopropyl)adenosine 
enhanced the enzyme activity, it is probable that 
endogenous adenosine in tissue pieces has a similar 
effect, Therefore, the adenosine ffect must be con- 
sidered when studying the regulation of lipoprotein 
lipase activity of isolated fat cells or adipose tissue 
pieces. 
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